Literature DB >> 12829424

Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction.

Claudio A Naranjo1, Alan Y Chu, Lescia K Tremblay.   

Abstract

Alcoholism is a complex disorder with symptoms ranging from abuse to dependence, often comorbid with depression, antisocial personality, or anxiety. Neurodevelopmental causes of the disorder are unknown but inferences are possible from current knowledge. Neurobiological studies implicate multiple brain changes, which may be characterized as premorbid or morbid. These studies have also examined specific aspects of the alcohol dependence syndrome, including alcohol reinforcement and craving. Here, we review the evidence for vulnerability factors in alcohol dependence, with an emphasis on central serotonin (5-HT) and dopamine (DA). Serotonin dysfunction likely contributes to the development of alcoholism since studies of alcohol-preferring rodents show decreased 5-HT function on many measures. We have shown that serotonin-enhancing drugs reduce consumption and craving in mild to moderate alcoholics, yet similar studies in severely dependent individuals remain inconclusive. Studies indicate that serotonin dysfunction may contribute to the development of dependence via impaired impulse control and/or mood regulation. The mesocorticolimbic dopamine pathway represents another important pathophysiological target in alcoholism. Differences in D(2) receptor density, dopamine sensitivity, and gene expression have been linked to consumption, reinforcement, craving, and relapse. However, while DA agonists reduce self-administration in animals, we found no effect in humans with long-acting bromocriptine, a D(2) agonist. Dopamine may contribute differentially to the development of dependence via its effects on alcohol wanting, reinforcement, and reward memory. Although animal experiments show consistent roles for serotonin and dopamine in alcohol dependence, human studies are not always concordant. Such discrepancies highlight the complexity of dependence-related behaviors in humans and of identifying vulnerabilities to alcoholism.

Entities:  

Year:  2002        PMID: 12829424     DOI: 10.1080/10298420290034231

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  218 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

2.  Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments.

Authors:  V Bassareo; G Di Chiara
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

Review 3.  The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.

Authors:  C A Naranjo; D M Knoke
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

Review 4.  Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.

Authors:  H R Kranzler
Journal:  Alcohol Alcohol       Date:  2000 Nov-Dec       Impact factor: 2.826

Review 5.  The efficacy of disulfiram: a review of outcome studies.

Authors:  J C Hughes; C C Cook
Journal:  Addiction       Date:  1997-04       Impact factor: 6.526

6.  Experience of a "slip" among alcoholics treated with naltrexone or placebo.

Authors:  S S O'Malley; A J Jaffe; S Rode; B J Rounsaville
Journal:  Am J Psychiatry       Date:  1996-02       Impact factor: 18.112

7.  Sex differences in the sources of genetic liability to alcohol abuse and dependence in a population-based sample of U.S. twins.

Authors:  C A Prescott; S H Aggen; K S Kendler
Journal:  Alcohol Clin Exp Res       Date:  1999-07       Impact factor: 3.455

8.  Young adult children of alcoholic, depressed and nondistressed parents.

Authors:  T Jacob; M Windle
Journal:  J Stud Alcohol       Date:  2000-11

9.  Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation.

Authors:  P A Garris; M Kilpatrick; M A Bunin; D Michael; Q D Walker; R M Wightman
Journal:  Nature       Date:  1999-03-04       Impact factor: 49.962

10.  Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.

Authors:  C A Naranjo; K E Bremner; K L Lanctôt
Journal:  Addiction       Date:  1995-01       Impact factor: 6.526

View more
  3 in total

1.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

2.  Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.

Authors:  George A Kenna; William H Zywiak; Robert M Swift; John E McGeary; James S Clifford; Jessica R Shoaff; Cynthia Vuittonet; Samuel Fricchione; Michael Brickley; Kayla Beaucage; Carolina L Haass-Koffler; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

3.  A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.

Authors:  George A Kenna; William H Zywiak; John E McGeary; Lorenzo Leggio; Chinatsu McGeary; Shirley Wang; Andrea Grenga; Robert M Swift
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.